Lessons from human teratomas to guide development of safe stem cell therapies

[1]  S. Lehmann,et al.  Comparative analysis of protein expression of three stem cell populations: models of cytokine delivery system in vivo. , 2013, International journal of pharmaceutics.

[2]  P. Opolon,et al.  Malignant germ cell-like tumors, expressing Ki-1 antigen (CD30), are revealed during in vivo differentiation of partially reprogrammed human-induced pluripotent stem cells. , 2012, The American journal of pathology.

[3]  Yilin Cao,et al.  Residual undifferentiated cells during differentiation of induced pluripotent stem cells in vitro and in vivo. , 2012, Stem cells and development.

[4]  L. Ährlund‐Richter,et al.  Early Events in Xenograft Development from the Human Embryonic Stem Cell Line HS181 - Resemblance with an Initial Multiple Epiblast Formation , 2011, PloS one.

[5]  R. Jaenisch,et al.  Blimp1 Expression Predicts Embryonic Stem Cell Development In Vitro , 2011, Current Biology.

[6]  D. Sahoo,et al.  An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells , 2011, Nature Biotechnology.

[7]  G. Jenster,et al.  Specific detection of OCT3/4 isoform A/B/B1 expression in solid (germ cell) tumours and cell lines: confirmation of OCT3/4 specificity for germ cell tumours , 2011, British Journal of Cancer.

[8]  H. Stoop,et al.  Expression and interdependencies of pluripotency factors LIN28, OCT3/4, NANOG and SOX2 in human testicular germ cells and tumours of the testis. , 2011, International journal of andrology.

[9]  A. Bang,et al.  Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells , 2011, Nature Biotechnology.

[10]  P. Andrews,et al.  Altered patterns of differentiation in karyotypically abnormal human embryonic stem cells. , 2011, The International journal of developmental biology.

[11]  R. Corn,et al.  Ultrasensitive microarray detection of short RNA sequences with enzymatically modified nanoparticles and surface plasmon resonance imaging measurements. , 2011, Analytical chemistry.

[12]  Weijun Su,et al.  Bioluminescence reporter gene imaging characterize human embryonic stem cell‐derived teratoma formation , 2011, Journal of cellular biochemistry.

[13]  T. Dresselaers,et al.  Effects of MRI Contrast Agents on the Stem Cell Phenotype , 2010, Cell transplantation.

[14]  J. Richter,et al.  Global DNA methylation in fetal human germ cells and germ cell tumours: association with differentiation and cisplatin resistance , 2010, The Journal of pathology.

[15]  H. Okabe,et al.  DNMT3L Is a Novel Marker and Is Essential for the Growth of Human Embryonal Carcinoma , 2010, Clinical Cancer Research.

[16]  Sailesh Gopalakrishna-Pillai,et al.  Astrocytes derived from trisomic human embryonic stem cells express markers of astrocytic cancer cells and premalignant stem-like progenitors , 2010, BMC Medical Genomics.

[17]  B. Gunawan,et al.  Malignant transformation of an untreated congenital sacrococcygeal teratoma: a amplification at 8q and 12p detected by comparative genomic hybridization. , 2010, Cancer genetics and cytogenetics.

[18]  S. Agee,et al.  Analytical validation of a highly sensitive microparticle-based immunoassay for the quantitation of IL-13 in human serum using the Erenna immunoassay system. , 2009, Journal of immunological methods.

[19]  Yan Wang,et al.  Detection of microRNA by fluorescence amplification based on cation-exchange in nanocrystals. , 2009, Analytical chemistry.

[20]  Robert Lanza,et al.  EMBRYONIC STEM CELLS / INDUCED PLURIPOTENT STEM CELLS Long-Term Safety and Function of RPE from Human Embryonic Stem Cells in Preclinical Models of Macular Degeneration , 2009 .

[21]  T. Ichisaka,et al.  Suppression of induced pluripotent stem cell generation by the p53–p21 pathway , 2009, Nature.

[22]  A. Connolly,et al.  Effects of cell number on teratoma formation by human embryonic stem cells , 2009, Cell cycle.

[23]  M. Mattson,et al.  Self-renewal and differentiation capabilities are variable between human embryonic stem cell lines I3, I6 and BG01V , 2009, BMC Cell Biology.

[24]  T. Putti,et al.  Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies. , 2009, Stem cell research.

[25]  R. Drut.  Immunohistochemical localization of nanog and Oct4 in stem cell compartments of human sacrococcygeal teratomas , 2009, Histopathology.

[26]  Kai Chen,et al.  Noninvasive de novo imaging of human embryonic stem cell-derived teratoma formation. , 2009, Cancer research.

[27]  Y. Arai,et al.  Yolk sac tumor but not seminoma or teratoma is associated with abnormal epigenetic reprogramming pathway and shows frequent hypermethylation of various tumor suppressor genes , 2009, Cancer science.

[28]  C. Busch,et al.  Isolation of three stem cell lines from human sacrococcygeal teratomas , 2009, The Journal of pathology.

[29]  U. Frandsen,et al.  Teratoma formation by human embryonic stem cells is site dependent and enhanced by the presence of Matrigel. , 2009, Stem cells and development.

[30]  K. Sermon,et al.  Recurrent chromosomal abnormalities in human embryonic stem cells , 2008, Nature Biotechnology.

[31]  J. Visvader,et al.  Cancer stem cells in solid tumours: accumulating evidence and unresolved questions , 2008, Nature Reviews Cancer.

[32]  J. Hicks,et al.  Global DNA hypomethylation in intratubular germ cell neoplasia and seminoma, but not in nonseminomatous male germ cell tumors , 2008, Modern Pathology.

[33]  Ryan D. Morin,et al.  Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. , 2008, Genome research.

[34]  G. Sauvageau,et al.  Polycomb Group Genes: Keeping Stem Cell Activity in Balance , 2008, PLoS biology.

[35]  K. Mason,et al.  Go with the flow for monitoring response in myeloma with minimal residual disease , 2008, Leukemia & lymphoma.

[36]  M. Slovak,et al.  Human embryonic stem cells are prone to generate primitive, undifferentiated tumors in engrafted human fetal tissues in severe combined immunodeficient mice. , 2007, Stem cells and development.

[37]  Maurizio Conti,et al.  An investigation of sensitivity limits in PET scanners , 2007 .

[38]  Lila R Collins,et al.  Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts , 2007, Nature Biotechnology.

[39]  N. Benvenisty,et al.  Clonal Analysis of Human Embryonic Stem Cell Differentiation into Teratomas , 2007, Stem cells.

[40]  P. Andrews,et al.  Culture adaptation of embryonic stem cells echoes germ cell malignancy. , 2007, International journal of andrology.

[41]  L. Looijenga,et al.  Why human extragonadal germ cell tumours occur in the midline of the body: old concepts, new perspectives. , 2007, International journal of andrology.

[42]  Aleksandar Dakic,et al.  Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells , 2007, Science.

[43]  G. Churchill,et al.  Characterization of human embryonic stem cell lines by the International Stem Cell Initiative , 2007, Nature Biotechnology.

[44]  V. Pantesco,et al.  A Meta‐Analysis of Human Embryonic Stem Cells Transcriptome Integrated into a Web‐Based Expression Atlas , 2007, Stem cells.

[45]  P. Andrews,et al.  Adaptation to culture of human embryonic stem cells and oncogenesis in vivo , 2007, Nature Biotechnology.

[46]  Kelly M. McGarvey,et al.  A stem cell–like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing , 2007, Nature Genetics.

[47]  G. Daley,et al.  In vitro generation of germ cells from murine embryonic stem cells , 2006, Nature Protocols.

[48]  M. Beal,et al.  Functional engraftment of human ES cell–derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes , 2006, Nature Medicine.

[49]  M. Stojkovic,et al.  Growth of teratomas derived from human pluripotent stem cells is influenced by the graft site. , 2006, Stem cells and development.

[50]  G. Reifenberger,et al.  Molecular genetic analysis of central nervous system germ cell tumors with comparative genomic hybridization , 2006, Modern Pathology.

[51]  Mariette Schrier,et al.  A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell Tumors , 2006, Cell.

[52]  Ernst Wolvetang,et al.  CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells , 2006, Nature Biotechnology.

[53]  P. Andrews,et al.  Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: opposite sides of the same coin. , 2005, Biochemical Society transactions.

[54]  S. Przyborski.  Differentiation of Human Embryonic Stem Cells After Transplantation in Immune‐Deficient Mice , 2005, Stem cells.

[55]  Megan F. Cole,et al.  Core Transcriptional Regulatory Circuitry in Human Embryonic Stem Cells , 2005, Cell.

[56]  L. Looijenga,et al.  Testicular germ-cell tumours in a broader perspective , 2005, Nature Reviews Cancer.

[57]  J. Thomson,et al.  A germ cell origin of embryonic stem cells? , 2005, Development.

[58]  D. Tibboel,et al.  Strategy for management of newborns with cervical teratoma , 2004, Journal of perinatal medicine.

[59]  M. Wendel,et al.  Organized development from human embryonic stem cells after injection into immunodeficient mice. , 2004, Stem cells and development.

[60]  S. Moon,et al.  Human embryonic stem cells express a unique set of microRNAs. , 2004, Developmental biology.

[61]  B. Lawrenz,et al.  Highly sensitive biosafety model for stem-cell-derived grafts. , 2004, Cytotherapy.

[62]  J. Nichols,et al.  Functional Expression Cloning of Nanog, a Pluripotency Sustaining Factor in Embryonic Stem Cells , 2003, Cell.

[63]  L. Strong,et al.  Germ cell tumours in neonates and infants: a distinct subgroup? , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[64]  M. Fritsch,et al.  Genetic analysis of mediastinal nonseminomatous germ cell tumors in children and adolescents , 2002, Genes, chromosomes & cancer.

[65]  J. Lebkowski,et al.  Human embryonic stem cells: culture, differentiation, and genetic modification for regenerative medicine applications. , 2001, Cancer journal.

[66]  M. Fritsch,et al.  Genetic analysis of childhood germ cell tumors with comparative genomic hybridization. , 2001, Klinische Padiatrie.

[67]  L. Looijenga,et al.  Comparative Genomic and In Situ Hybridization of Germ Cell Tumors of the Infantile Testis , 2000, Laboratory Investigation.

[68]  D. Harms,et al.  Germ-cell tumors in childhood and adolescence , 2000 .

[69]  M. Devouassoux‐Shisheboran,et al.  Microdissection-based analysis of mature ovarian teratoma. , 1999, The American journal of pathology.

[70]  K. Sano.  Pathogenesis of intracranial germ cell tumors reconsidered , 1999 .

[71]  E. Perlman,et al.  DNA content of ovarian immature teratomas and malignant germ cell tumors. , 1998, Gynecologic oncology.

[72]  C. Stolar,et al.  Immature teratomas in children: pathologic considerations: a report from the combined Pediatric Oncology Group/Children's Cancer Group. , 1998, The American journal of surgical pathology.

[73]  K. Sano,et al.  Pathogenesis of intracranial germ cell tumors reconsidered. , 1998, Journal of neurosurgery.

[74]  L. Looijenga,et al.  Chromosomal constitution and developmental potential of human germ cell tumors and teratomas. , 1997, Cancer genetics and cytogenetics.

[75]  G. Mead,et al.  Primary pure teratoma of the testis. , 1996, The Journal of urology.

[76]  D. O'connor,et al.  The influence of grade on the outcome of stage I ovarian immature (malignant) teratomas and the reproducibility of grading. , 1994, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[77]  G. Hansson,et al.  Sacrococcygeal teratoma in Sweden: a 10-year national retrospective study. , 1992, Journal of pediatric surgery.

[78]  U. Surti,et al.  Genetics and biology of human ovarian teratomas. III. Cytogenetics and origins of malignant ovarian germ cell tumors. , 1992, Cancer genetics and cytogenetics.

[79]  W. van Putten,et al.  Ploidy of testicular carcinoma in situ. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[80]  R. C. Silver,et al.  Opposite sides of the same coin: Former spouses' divergent perspectives in coping with their divorce. , 1990 .

[81]  U. Surti,et al.  Genetics and biology of human ovarian teratomas. I. Cytogenetic analysis and mechanism of origin. , 1990, American journal of human genetics.

[82]  J. Rossant,et al.  The relationship between embryonic, embryonal carcinoma and embryo-derived stem cells. , 1984, Cell differentiation.

[83]  Craig R Moores,et al.  H-40, an antigen controlled by an Igh linked gene and recognized by cytotoxic T lymphocytes. I. Genetic analysis of H-40 and distribution of its product on B cell tumors , 1984, The Journal of experimental medicine.

[84]  F. Gonzalez-crussi,et al.  Sacrococcygeal teratomas in infants and children: relationship of histology and prognosis in 40 cases. , 1978, Archives of pathology & laboratory medicine.

[85]  H. Norris,et al.  Immature (malignant) teratoma of the ovary. A clinical and pathologic study of 58 cases , 1976, Cancer.

[86]  S. Moon,et al.  Effect of chromosome instability on the maintenance and differentiation of human embryonic stem cells in vitro and in vivo. , 2011, Stem cell research.

[87]  A. Schnerch,et al.  Characterization of human embryonic stem cells with features of neoplastic progression , 2009, Nature Biotechnology.

[88]  L. Looijenga,et al.  The distribution and behavior of extragonadal primordial germ cells in Bax mutant mice suggest a novel origin for sacrococcygeal germ cell tumors. , 2008, The International journal of developmental biology.

[89]  Thomas D. Schmittgen,et al.  Real-time PCR quantification of precursor and mature microRNA. , 2008, Methods.

[90]  Mark Shackleton,et al.  Efficient tumour formation by single human melanoma cells , 2008 .

[91]  N. Benvenisty,et al.  The tumorigenicity of human embryonic stem cells. , 2008, Advances in cancer research.

[92]  P. Haentjens,et al.  Study of the factors associated with recurrence in children with sacrococcygeal teratoma. , 2006, Journal of pediatric surgery.

[93]  Marcos González,et al.  Minimal residual disease monitoring in multiple myeloma: a comparison between allelic-specific oligonucleotide real-time quantitative polymerase chain reaction and flow cytometry. , 2005, Haematologica.

[94]  D. Harms,et al.  Germ-cell tumors in childhood and adolescence. GPOH MAKEI and the MAHO study groups. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[95]  R. O’rahilly,et al.  Neurulation in the normal human embryo. , 1994, Ciba Foundation symposium.

[96]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.